Anticoagulation Regimen Safety Index (Warfarin vs LMWH) Calculator

Clinical calculation support · Verify results before clinical use

Patient factors

Enter the available clinical factors for an educational checklist.

Educational tool

Use the patient's age in completed years.

Enter a clinically assessed CrCl value; do not substitute eGFR without considering the dosing guidance for the specific medicine.

History of major bleeding

Select the option that applies.

Concurrent antiplatelet therapy

Includes current concomitant use of an antiplatelet medicine.

Clinical context and limitations

Bleeding risk during anticoagulation depends on the indication, anticoagulant agent and dose, renal and hepatic function, previous bleeding, concomitant medicines, and other patient-specific factors. A short checklist cannot capture all of these considerations.

How to use this page

  • Use the selected factors as prompts for a fuller medication and bleeding-risk review.
  • Check the specific anticoagulant's prescribing information and current guideline for renal impairment and dose adjustment.
  • Do not interpret the prototype point total as an absolute probability, validated risk category, or comparative treatment recommendation.

About the displayed points

The arithmetic from the supplied prototype is retained for transparency, but the weights and cutoffs have not been verified as a validated score for choosing between warfarin and LMWH. The original low/moderate/high categories and the claim that LMWH should be preferred at high scores have therefore been removed.

References and evidence notes

Schulman S, Kearon C; ISTH SSC.

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–694.

https://doi.org/10.1111/j.1538-7836.2005.01204.x

This paper defines major bleeding for clinical investigations; it does not validate the score or recommend LMWH over warfarin based on this point total.

American Society of Hematology.

Guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Read the guideline on PubMed Central

Guideline recommendations are indication- and context-specific; they should be consulted directly rather than inferred from this prototype score.

Clinical disclaimer: This educational checklist is not a validated clinical decision rule and does not provide an individualized treatment recommendation. Anticoagulant selection and dosing must be based on the indication, patient characteristics, official prescribing information, current guidelines, and clinician judgement.